The Future of CDI
Use of tuberculin skin test, chest radiograph and interferon-gamma release assay to select migrants for treatment of latent tuberculosis
Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998–2015
Meru Sheel, Frank Beard, Helen Quinn, Aditi Dey, Martyn Kirk, Ann Koehler, Peter Markey, Peter McIntyre, Kristine Macartney || PII: S2209-6051(18)00002-7 || Published online: 12/09/2018
Full Text (Word 1.03 MB) (PDF 3.46 MB)
Distribution of Bacillus Calmette–Guérin (BCG) Vaccine in Victoria 2013-2015
An Outbreak of Paralytic Shellfish Poisoning in Tasmania
Evaluation of Australia’s Enhanced Invasive Pneumococcal Disease (IPD) Surveillance Program
Australian Paediatric Surveillance Unit Annual Report, 2017
Suzy Teutsch, Yvonne Zurynski, Elizabeth Elliott, and all chief investigators of APSU surveillance studies || PII:S2209-6051(18)00006-4 || Published online: 12/09/2018
Full Text (Word 498 KB) (PDF 3.81 MB)
Editorial teamThe Editorial team consists of the Editor, Deputy Editors, and two publication staff. The Editorial team is supported by an Editorial advisory board.
Phil WrightEditorial and Production Staff
Leroy TrapaniEditorial Advisory Board
The role of the CDI Editorial Advisory Board (EAB) is to: provide expert advice to the CDI editorial team; advocate for CDI in the broader community; serve as a critical sounding board for the editorial team on editorial ideas and themes; provide ideas for features and news and thoughts on current trends; and provide constructive feedback on published issues.
Correspondence should be sent to: firstname.lastname@example.org
ISSN: 2209-6051 (Online)
Opinions expressed in Communicable Diseases Intelligence are those of the authors and not necessarily those of the Australian Government Department of Health or the Communicable Diseases Network Australia. Data may be subject to revision.